Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 37OTHER_GOV 2NIH 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 71Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 54Prostatic Neoplasms 48Lung Neoplasms 48Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Interventions

Metformin 2Medroxyprogesterone Acetate 1Levonorgestrel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Endometrial Hyperplasia × Clear all
NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting
165 enrolled
Gynecologic

Endometrial Hyperplasia

NCT02872818 2016-08-23

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

Kayseri Education and Research Hospital

Phase 4 Completed
40 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡